REVERE PHARMACEUTICALS

Revere Pharmaceuticals is headquartered in Boston and conducts research in our San Diego laboratory, supported by a network of research partners in the U.S., Canada, and India... At Revere, we are developing small molecule drugs targeting Rac1 and its genomic variants, members of the Ras-homologous (Rho) family of GTPases. These key signaling proteins function as molecular switches which are commonly dysregulated in many cancers and other diseases, including chronic kidney disease, viral infections such as COVID-19, and Alzheimer's disease.

Also known as: Revere

Primary location: Arlington United States